- 3201. Douche
- [washing of a body cavity or surface for therapeutic purposes by flowing solution which is inserted and then removed; drugs in the irrigation solution may be absorbed. ( CSP )] (UMLS (NCI) C0022100) =Therapeutic or Preventive Procedure =Therapeutic Interventions;
RouteByMethod =bronchoalveolar lavage;
Irrigation, genitourinary;
Irrigation, intralesional;
Irrigation, intraocular;
Irrigation, urinary bladder;
Irrigation, intragastric;
Irrigation, rectal;
| - 3251. DOX/IFF/MTP-PE Liposome/MTX
- (UMLS (NCI) C0281526) =Therapeutic or Preventive Procedure
|
- 3202. Douche, vaginal
- [Douche, vaginal ( HL7V3.0 )] (UMLS (HL7) C1553210) =Spatial Concept =VaginalRoute;
Douche | - 3252. DOX/IFF/MTX
- (UMLS (NCI) C0279209) =Therapeutic or Preventive Procedure
|
- 3203. Doughnut Cell
- (UMLS (NCI) C0427519) =Laboratory or Test Result
| - 3253. DOX/IFF/PRED/VCR
- (UMLS (NCI) C0279185) =Therapeutic or Preventive Procedure
|
- 3204. Douglas Indian Association
- (UMLS (HL7) C1550847) =Population Group =NativeEntityAlaska;
| - 3254. DOX/IFF/VCR
- (UMLS (NCI) C0279210) =Therapeutic or Preventive Procedure
|
- 3205. Douroucoulis
- [A species in the family AOTIDAE, inhabiting the forested regions of Central and South America (from Panama to the Amazon). Vocalizations occur primarily at night when they are active, thus they are also known as Northern night monkeys. ( MSH )] (UMLS (CSP) C0003518) =Mammal
| - 3255. DOX/IFF/VP-16
- (UMLS (NCI) C0677752) =Therapeutic or Preventive Procedure ;
|
- 3206. Down syndrome
- [A disorder caused by the presence of an extra chromosome 21 and characterized by mental retardation and distinguishing physical features. ( NCI )] (UMLS (CSP) C0013080) =Congenital Abnormality; Disease or Syndrome ;
=Abnormalities, Multiple;
Chromosomal anomalies;
Arrieration mentale;
syndrome;
Chromosomal Disorders, Nervous System;
| - 3256. DOX/IFN-A
- (UMLS (NCI) C0338120) =Therapeutic or Preventive Procedure ;
|
- 3207. Down-Regulated in Rhabdomyosarcoma LIM Protein
- [Members of the four-and-a-half-LIM domain (FHL) protein family, which are expressed in a tissue- and stage-specific manner, have been reported to function as transcriptional coactivators. Expression of DRAL (FHL2) results in enhancement of NF-kappaB activation. DRAL (FHL2) is a p53-responsive gene implicated in induction of apoptosis. DRAL may participate in a regulatory mechanism that coordinates cellular responses controlled by NF-kappaB transcription factor. (from J Biol Chem 2002;277:37045-53 and FEBS Lett 2002;521(1-3):165-9) ( NCI )] (UMLS (NCI) C1333635) FHL2;
Four and a Half LIM Domains 2;
Four and a Half LIM Domains 2 Protein;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 3257. DOX/IL-2
- (UMLS (NCI) C0278683) =Therapeutic or Preventive Procedure
|
- 3208. Down-Regulator of Transcription 1
- [Encoded by human DR1 Gene, TATA-Binding Protein-Associated Phosphoprotein represses both basal and activated levels of transcription. DR1 phosphorylation affects its interaction with TBP. The DR1 protein contains a histone fold motif at the amino terminus, a TBP-binding domain, and a glutamine- and alanine-rich region and represses transcription with DRAP1 by inhibiting pre-initiation complex formation through interaction with TFIID and DNA. The binding of DR1 repressor complexes to TBP-promoter complexes may establish a mechanism in which an altered DNA conformation, together with the formation of higher order complexes, inhibits the assembly of the preinitiation complex and controls the rate of RNA polymerase II transcription. (NCI) ( NCI )] (UMLS (NCI) C0170954) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 3258. DOX/KCZ
- (UMLS (NCI) C0281712) =Therapeutic or Preventive Procedure
|
- 3209. Down-Regulator of Transcription 1, TBP-Binding (Negative Cofactor 2) Gene
- [This gene is involved in repression of transcription. ( NCI )] (UMLS (NCI) C1333247) DR1;
DR1 Gene;
=Gene or Genome ;
| - 3259. DOX/L-PAM/MePRDL
- (UMLS (NCI) C0281313) =Therapeutic or Preventive Procedure ;
|
- 3210. Downward Ocular Deviation
- [Vertical strabismus in which there is permanent downward deviation of the visual axis of one eye. ( NCI )] (UMLS (NCI) C0152208) =Finding ;
| - 3260. DOX/L-PAM/VM-26
- (UMLS (NCI) C0279939) =Therapeutic or Preventive Procedure
|
- 3211. DOX-MTC
- [A formulation of doxorubicin bound to microscopic beads of activated carbon and iron (magnetic targeted carriers). Doxorubicin intercalates between base pairs in the DNA helix, thereby preventing DNA replication and ultimately inhibiting protein synthesis. Additionally, doxorubicin inhibits topoisomerase II which results in an increased and stabilized cleavable enzyme-DNA linked complex during DNA replication and subsequently prevents the ligation of the nucleotide strand after double-strand breakage. Doxorubicin also forms oxygen free radicals resulting in cytotoxicity secondary to lipid peroxidation of cell membrane lipids. The placement of a magnet on the body surface overlying a tumor site facilitates this carrier complex to deliver doxorubicin directly to the tumor, thereby prolonging the duration of the therapeutic effects while decreasing systemic toxicity. ( NCI )] (UMLS (NCI) C1134452) Doxorubicin-Magnetic Targeted Carrier Complex;
MTC-DOX;
=Organic Chemical; Pharmacologic Substance | - 3261. DOX/MeCCNU
- (UMLS (NCI) C0279380) =Therapeutic or Preventive Procedure
|
- 3212. DOX-SL
- (UMLS (NCI) C0701182) =Organic Chemical; Pharmacologic Substance ;
| - 3262. DOX/MeCCNU/SZC
- (UMLS (NCI) C0279268) =Therapeutic or Preventive Procedure
|
- 3213. DOX/5-FU/GM-CSF/MTX
- (UMLS (NCI) C0280205) =Therapeutic or Preventive Procedure
| - 3263. DOX/MePRDL
- (UMLS (NCI) C0796442) Doxorubicin/Methylprednisolone =Therapeutic or Preventive Procedure ;
|
- 3214. DOX/5-FU/L-PAM
- (UMLS (NCI) C0279389) =Therapeutic or Preventive Procedure
| - 3264. DOX/MITO
- (UMLS (NCI) C0279188) =Therapeutic or Preventive Procedure
|
- 3215. DOX/5-FU/L-PAM/TMX
- (UMLS (NCI) C0279796) =Therapeutic or Preventive Procedure
| - 3265. DOX/MITO/VBL
- (UMLS (NCI) C0052712) =Therapeutic or Preventive Procedure ;
|
- 3216. DOX/5-FU/MeCCNU
- (UMLS (NCI) C0280593) =Therapeutic or Preventive Procedure
| - 3266. DOX/MITO/VP-16
- (UMLS (NCI) C0280065) =Therapeutic or Preventive Procedure
|
- 3217. DOX/5-FU/MITO/MTX
- (UMLS (NCI) C0279534) =Therapeutic or Preventive Procedure
| - 3267. DOX/MP/MTX/PRED/VCR
- (UMLS (NCI) C0278924) =Therapeutic or Preventive Procedure
|
- 3218. DOX/5-FU/MITO/SZC
- (UMLS (NCI) C0207828) =Therapeutic or Preventive Procedure
| - 3268. DOX/MTX
- (UMLS (NCI) C0281523) =Therapeutic or Preventive Procedure
|
- 3219. DOX/5-FU/MITO/TZT
- (UMLS (NCI) C0279447) =Therapeutic or Preventive Procedure
| - 3269. DOX/MTX/PRED/VCR
- (UMLS (NCI) C0279197) =Therapeutic or Preventive Procedure
|
- 3220. DOX/5-FU/MITO/VCR
- (UMLS (NCI) C0280592) =Therapeutic or Preventive Procedure
| - 3270. DOX/MTX/VCR
- (UMLS (NCI) C0280061) =Therapeutic or Preventive Procedure
|
- 3221. DOX/5-FU/MTX
- (UMLS (NCI) C0051571) =Therapeutic or Preventive Procedure ;
| - 3271. DOX/PCB/PRED/VCR
- (UMLS (NCI) C0058827) =Therapeutic or Preventive Procedure ;
|
- 3222. DOX/5-FU/MTX/PRED/TSPA/VBL
- (UMLS (NCI) C0279278) =Therapeutic or Preventive Procedure ;
| - 3272. DOX/PCPZ
- (UMLS (NCI) C0280750) =Therapeutic or Preventive Procedure
|
- 3223. DOX/5-FU/TMX/TSPA
- (UMLS (NCI) C0280699) =Therapeutic or Preventive Procedure
| - 3273. DOX/PEG-ASP/PRED/VCR
- (UMLS (NCI) C0281219) =Therapeutic or Preventive Procedure ;
|
- 3224. DOX/5-FU/TSPA
- (UMLS (NCI) C0280681) =Therapeutic or Preventive Procedure
| - 3274. DOX/PRDL/VCR
- (UMLS (NCI) C0281484) =Therapeutic or Preventive Procedure
|
- 3225. DOX/5-FU/TZT
- (UMLS (NCI) C0279453) =Therapeutic or Preventive Procedure
| - 3275. DOX/PRED
- (UMLS (NCI) C0279013) =Therapeutic or Preventive Procedure ;
|
- 3226. DOX/5-FU/VBL
- (UMLS (NCI) C0279998) =Therapeutic or Preventive Procedure
| - 3276. DOX/PRED/VM-26
- (UMLS (NCI) C0279511) =Therapeutic or Preventive Procedure
|
- 3227. DOX/5-FU/VNB
- (UMLS (NCI) C0281298) =Therapeutic or Preventive Procedure
| - 3277. DOX/PRED/VP-16
- (UMLS (NCI) C0279891) =Therapeutic or Preventive Procedure
|
- 3228. DOX/DPPE
- (UMLS (NCI) C0392975) =Therapeutic or Preventive Procedure ;
| - 3278. DOX/progesterone
- (UMLS (NCI) C0392995) =Therapeutic or Preventive Procedure
|
- 3229. DOX/DuP-941
- (UMLS (NCI) C0338273) =Therapeutic or Preventive Procedure ;
| - 3279. DOX/PSC 833
- (UMLS (NCI) C0392966) =Therapeutic or Preventive Procedure ;
|
- 3230. DOX/EDAM
- (UMLS (NCI) C0281407) =Therapeutic or Preventive Procedure ;
| - 3280. DOX/QND
- (UMLS (NCI) C0280652) =Therapeutic or Preventive Procedure
|
- 3231. DOX/EM
- (UMLS (NCI) C0338295) =Therapeutic or Preventive Procedure
| - 3281. DOX/QND/VP-16
- (UMLS (NCI) C0279040) =Therapeutic or Preventive Procedure
|
- 3232. DOX/EM/KCZ/VBL
- (UMLS (NCI) C0677757) =Therapeutic or Preventive Procedure
| - 3282. DOX/SUR
- (UMLS (NCI) C0280983) =Therapeutic or Preventive Procedure
|
- 3233. DOX/ESDL/TSPA/VBL/ZDX
- (UMLS (NCI) C0280898) =Therapeutic or Preventive Procedure
| - 3283. DOX/SZC
- (UMLS (NCI) C0281271) =Therapeutic or Preventive Procedure
|
- 3234. DOX/Ethiodized Oil
- (UMLS (NCI) C0280636) =Therapeutic or Preventive Procedure
| - 3284. DOX/TAX
- (UMLS (NCI) C0280905) =Therapeutic or Preventive Procedure
|
- 3235. DOX/FT/MITO
- (UMLS (NCI) C0279365) =Therapeutic or Preventive Procedure
| - 3285. DOX/TOPO
- (UMLS (NCI) C0281396) =Therapeutic or Preventive Procedure ;
|
- 3236. DOX/FUDR
- (UMLS (NCI) C0278914) =Therapeutic or Preventive Procedure
| - 3286. DOX/Trifluoperazine/VBL/VPAM
- (UMLS (NCI) C0281142) =Therapeutic or Preventive Procedure
|
- 3237. DOX/FUDR/MITO
- (UMLS (NCI) C0280007) =Therapeutic or Preventive Procedure
| - 3287. DOX/TSPA
- (UMLS (NCI) C0280987) =Therapeutic or Preventive Procedure
|
- 3238. DOX/FXM/TMX/TSPA/VBL
- (UMLS (NCI) C0279272) =Therapeutic or Preventive Procedure
| - 3288. DOX/TSPA/VBL
- (UMLS (NCI) C0279686) =Therapeutic or Preventive Procedure
|
- 3239. DOX/FXM/TSPA/VBL
- (UMLS (NCI) C0075860) =Therapeutic or Preventive Procedure
| - 3289. DOX/VBL
- (UMLS (NCI) C0280930) =Therapeutic or Preventive Procedure
|
- 3240. DOX/G-CSF
- (UMLS (NCI) C0281141) =Therapeutic or Preventive Procedure
| - 3290. DOX/VBL/VP-16
- (UMLS (NCI) C0255874) =Therapeutic or Preventive Procedure
|
- 3241. DOX/G-CSF/IFF
- (UMLS (NCI) C0281618) =Therapeutic or Preventive Procedure
| - 3291. DOX/VCR/VP-16
- (UMLS (NCI) C0078136) =Therapeutic or Preventive Procedure
|
- 3242. DOX/G-CSF/MP/PRED/VCR
- (UMLS (NCI) C0281131) =Therapeutic or Preventive Procedure
| - 3292. DOX/VCR/VX-710
- (UMLS (NCI) C0796603) Doxorubicin/Vincristine/VX-710 =Therapeutic or Preventive Procedure
|
- 3243. DOX/G-CSF/PRED/VCR
- (UMLS (NCI) C0281132) =Therapeutic or Preventive Procedure
| - 3293. DOX/VNB
- (UMLS (NCI) C0281256) =Therapeutic or Preventive Procedure ;
|
- 3244. DOX/G-CSF/TAX
- (UMLS (NCI) C0280906) =Therapeutic or Preventive Procedure
| - 3294. DOX/VPAM
- (UMLS (NCI) C0281009) =Therapeutic or Preventive Procedure
|
- 3245. DOX/G-CSF/TSPA
- (UMLS (NCI) C0280986) =Therapeutic or Preventive Procedure
| - 3295. DOX/VX-710
- (UMLS (NCI) C0338355) =Therapeutic or Preventive Procedure ;
|
- 3246. DOX/GM-CSF
- (UMLS (NCI) C0280753) =Therapeutic or Preventive Procedure
| - 3296. Doxacurium Chloride
- (UMLS (NCI) C0114872) =Organic Chemical; Pharmacologic Substance ;
=doxacurium;
=DOXACURIUM CHLORIDE 1 MG/ML |
- 3247. DOX/GM-CSF/IFF
- (UMLS (NCI) C0279011) =Therapeutic or Preventive Procedure ;
| - 3297. DOXAPRAM
- [A respiratory stimulant with analeptic activity. Doxapram, independent of oxygen levels, directly stimulates the peripheral carotid chemoreceptors, possibly by inhibiting the potassium channels of type I cells within the carotid body, thereby stimulating catecholamines release. This results in the prevention or reversal of both narcotic- and CNS depressant-induced respiratory depression. ( NCI )] (UMLS (NCI) C0013084) =Organic Chemical; Pharmacologic Substance ;
=Pyrrolidinones;
[RE900] RESPIRATORY AGENTS, OTHER =1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone Monohydrochloride, Monohydrate |
- 3248. DOX/HU
- (UMLS (NCI) C0281440) =Therapeutic or Preventive Procedure
| - 3298. DOXAZOSIN
- [A quinazoline with antihypertensive and antineoplastic properties. Doxazosin is an alpha-adrenergic antagonist that selectively inhibits alpha-1 adrenergic receptors. Blockages of the alpha-1 adrenergic action on the vascular smooth muscles lead to a decrease in vascular resistance and antihypertensive activity. This agent also shows high affinity to alpha-1c adrenoceptor, the predominant functional type in the prostate, which may partially attribute to its effect in treatment of benign prostatic hyperplasia. Furthermore, doxazosin induces apoptosis in prostate cancer cells mediated through inhibition of protein kinase B (PKB)/Akt-signaling death receptor regulatory pathway. ( NCI )] (UMLS (NCI) C0114873) =Organic Chemical; Pharmacologic Substance ;
=1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine;
[CV150] ALPHA-BLOCKERS/RELATED =DOXAZOSIN MESYLATE |
- 3249. DOX/ICI D1694
- (UMLS (NCI) C0677753) =Therapeutic or Preventive Procedure ;
| - 3299. Doxefazepam
- (UMLS (NCI) C0114875) =Organic Chemical; Pharmacologic Substance ;
|
- 3250. DOX/IFF
- (UMLS (NCI) C0278906) =Therapeutic or Preventive Procedure
| - 3300. doxepin
- [A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors. ( MSH )] (UMLS (CSP) C0013085) =Organic Chemical; Pharmacologic Substance ;
=[CN601] TRICYCLIC ANTIDEPRESSANTS;
Dibenzoxepins;
[DE900] DERMATOLOGICALS, TOPICAL OTHER;
=DOXEPIN HYDROCHLORIDE |
home
